HAKAI was initially identified as an E-cadherin-binding protein that degrades E-cadherin by ubiquitinating E-cadherin, and functional studies revealed that HAKAI plays roles in cell proliferation and tumor progressionin vivo[76]. Here, CDH1 is linked to neoplasm.